Fernando Holguin, MD
- Director, Asthma Program at the Center for Lungs and Breathing and
Executive Director, Latino Research and Policy Center at the Colorado
School of Public Health, University of Colorado Anschutz.
A native of Mexico City, Dr. Holguin attended medical
school at La Salle University. He continued his postgraduate education
at Emory University in Atlanta, Georgia where as chief resident, he
successfully completed an internal medicine residency. He then continued
his training with a fellowship in pulmonary and critical care.
Dr.
Holguin returned to Mexico where he joined the National Institute of
Public Health and developed research programs in respiratory and
cardiovascular health studying the effects of air pollution. He was
recruited back to Emory University as an assistant professor and joined
the Centers for Disease Control and Prevention (CDC) as a medical
epidemiologist. During his tenure as Emory faculty, Dr Holguin directed
the Grady Hospital Asthma Clinic and obtained his master’s degree in
public health and epidemiology.
He continued his academic
career as associate professor at the University of Pittsburgh, where he
co-directed the Asthma Institute, directed the Clinical and
Translational Research Center at Montefiore Hospital and founded the
Pulmonary Translational Research Core at the University of Pittsburgh
Medical Center.
Dr. Holguin currently directs the Asthma
Program at the Center for Lungs and Breathing at the University of
Colorado Anschutz Medical Campus and is the Executive Director for the
Latino Research and Policy Center at the Colorado School of Public
Health.
Over his career, Dr. Holguin has been awarded several
teaching and research awards and has received funding by the CDC,
Environmental Protection Agency and National Institutes of Health among
others. He has authored and co-authored over 120 papers and is
internationally known for his work in asthma and COPD; currently serves
as the co-chair of the American Thoracic Society and European
Respiratory Society Task Force on severe asthma.